1.06k likes | 1.25k Views
Initiation of Science. SCIENTIFIC METHODOLOGY OF LEARNING, CLINICAL PRACTICE AND RESEARCH IN AYURVEDA The process of learning, research and clinical practice are scientific and evidence based. Like other systems of ancient Indian learning, Ayurveda is discovered through most suitable sources (Pa
E N D
1. AN INSIGHT ON RESEARCH AND DEVELOPMENT IN CCRAS WITH SPECIAL FOCUS ON
DEVELOPMENT OF AYUSH QOL -2 FOR IMPROVEMENT OF QUALITY OF LIFE (QOL)IN HIV / AIDS
2. Initiation of Science
5.
13. CLINICAL TRIALS OF SELECTED CODED FORMULATION (OF WHICH STANDARDIZATION, SAFETY AND TOXICITY STUDIES BIOLOGICAL/TARGETED ACTIVITY STUDIES ARE IN PIPE LINE) ON SELECTED CLINICAL CONDITIONS. 1. Ayush-RCH-2 for Menopausal syndrome 2 . Ayush-CARD for Chronics stable Angina (Hridroga) 3. Ayush-UT for Urolithiasis (Mutrashmari) 4. Ayush-for DIAB Diabetes (Madhumeha) 5. Ayush-RHU-2 and Erand Taila-oil of Ricinus communis for Rheumatoid Arthritis (Amavata). 6. Ayush-RCH-1 and Ayush-RCH-3 for DUB(Animitta raktapradara) 7. Ayush-BA for Tamaka Swasa 8. Ayush-VJ-1and -Ayush-VJ-2 for Malaria (Vishama jwara)
16. COLLABORATIVE RESEARCH
23.
Development Of AYUSH QOL-2
29. The most prevalent users of Ayurveda /TSM are individuals who have incurable, non–life-threatening conditions that may be chronic.
The second largest group of users are those struggling with chronic, potentially life-threatening diseases, such as cancer and HIV-AIDS.
Both groups turn to Ayurveda /TSM for a variety of reasons, such as to improve immune functioning, to improve overall functioning, to increase quality of life, to cope with side effects from conventional therapies, and to relieve symptoms related to their illness.
30. Various historic and sociopolitical exigencies have contributed to the popularity of Ayurveda use for people living with HIV-AIDS.
Early in the struggle with HIV, pharmacologic treatments were limited and often were accompanied by severe negative side effects that precluded their use.
Later, with the advent of highly active antiretroviral therapies (HAART), access to these expensive therapies was limited for many communities.
31. THERE ARE MANY REASONS WHY PEOPLE LIVING WITH HIV/AIDS USE AYUSH TREATMENTS
Limitations of Anti-retro Viral Drugs to be used in our country include
1 Restricted availability in our country.
2. Major side effects
3. High cost
The physicians who work in integrated clinics that provide both conventional and complementary services may refer patients to these clinics for pain management, to learn adaptive coping strategies, to manage chronic and serious medical illness, and to manage HIV-related symptoms.
32. The social role of Ayurveda among people living with HIV-AIDS has been examined.
Some studies have examined the effectiveness of Ayurveda on symptom management and improvement of quality of life .
The management of HIV-related symptomatology has become important because people living with HIV-AIDS are living longer as a result of HAART.
Acceptance that a cure for HIV will not be discovered in the near future has justifiably shifted attention to quality of life concerns for people living with HIV-AIDS and consequently redirected attention to improving the management of HIV-
related symptoms
In addition, individuals who choose not to use HAART, who have limited access to conventional treatments, or who cannot tolerate the side effects of HAART (highly active anti retro viral therapy) may turn to Ayurveda for relief of HIV-related symptoms.
33. AYURVEDA PROVIDES …..
a comprehensive individualistic approach for the selection of appropriate therapy considering the body as a whole not merely treating the disease
Besides this Ayurvedic
-Rasayana
-Swastavritta
-Sadvritta
provides various drugs /counseling regimens to combat
stress related problems there by improving immunity and QOL.
46. Methodology -Development Of AYUSH QOL-2
47. -Keeping the global prevalence of HIV/AIDS and potentials of Ayurveda in view, the council has formulated and developing AYUSH QOL-2 for symptom management, Improvement of quality of Life through extensive pre clinical standardization /safety /targeted activity studies.
56. The preclinical safety and toxicity (Acute/Sub-acute) studies have been conducted adopting International norms and revealed its safety.
70. - The /Biological activity study reveals significant immunomodulator, adaptogenic activities(antagonized the effect of Cyclophosphamide and confirmed immunomodulatory effect * P<0.001 ) which are essential for improvement quality of life and symptoms management in HIV/AIDS.
72. FORCED SWIMMING TEST
76. TAIL SUSPENSION TEST
80. NEUTROPHIL COUNT